Follow-Up Study to Assess Long-Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment Studies

Trial Profile

Follow-Up Study to Assess Long-Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment Studies

Recruiting
Phase of Trial: Phase III

Latest Information Update: 06 Aug 2017

At a glance

  • Drugs Retosiban (Primary) ; Atosiban
  • Indications Preterm labour
  • Focus Adverse reactions; Registrational
  • Acronyms ARIOS
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 05 May 2017 Planned End Date changed from 1 Mar 2028 to 29 Jul 2022.
    • 05 May 2017 Planned primary completion date changed from 1 Mar 2024 to 29 Jul 2022.
    • 05 Jul 2016 Planned End Date changed from 1 Mar 2024 to 1 Mar 2028.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top